This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Swedish Orphan Biovitrum Ag, Swedish Orphen Biovitrum Ag. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Geneva, CH (2021)
- Basel, CH (2022)
Company Filing History:
Years Active: 2021-2025
Title: Fabrizio De Benedetti: Innovator in Medical Treatments
Introduction
Fabrizio De Benedetti is a prominent inventor based in Geneva, Switzerland. He has made significant contributions to the field of medical treatments, particularly in relation to interferon-gamma related indications. With a total of 6 patents to his name, his work has the potential to impact many lives.
Latest Patents
De Benedetti's latest patents include innovative methods and compositions for treating or preventing conditions associated with elevated levels of interferon-gamma (IFN-γ). One of his notable patents focuses on methods, compositions, and dosing regimens aimed at treating, preventing, or alleviating symptoms related to elevated IFN-γ levels. Another significant patent addresses the diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers. This includes methods for treating hemophagocytic lymphohistiocytosis (HLH) and other related disorders.
Career Highlights
Throughout his career, Fabrizio De Benedetti has worked with notable companies such as Swedish Orphan Biovitrum AG. His expertise in the medical field has allowed him to develop groundbreaking treatments that address complex health issues.
Collaborations
De Benedetti has collaborated with esteemed colleagues, including Walter Ferlin and Cristina De Min. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Fabrizio De Benedetti is a distinguished inventor whose work in medical treatments has the potential to change lives. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile